Where this oesophageal cancer information comes from
On this page are the major sources of information that we use to put together this section.
All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this page. We also try to find patients to review all our sections. If you have had oesophageal cancer, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.
Cancer Research UK
US National Cancer Institute
Information on the treatment of oesophageal cancer
Principles and practice of oncology (9th edition)
De Vita, VT, Lawrence TS and Rosenberg SA.
Lippincott, Williams and Wilkins, 2011
Cancer and its management (6th edition)
Tobias J and Hochhauser D
TNM Classification of Malignant Tumours (7th edition)
International Union Against Cancer
L.H. Sobin, M.K. Gospodarowicz, Ch. Wittekind
John Wiley and Sons, Hoboken, New Jersey, 2009
AJCC Cancer Staging Manual (7th edition)
American Joint Committee on Cancer
Guidelines for the management of oesophageal and gastric cancer
British Society of Gastroenterology (BSG), 2011
Management of oesophageal and gastric cancer
Scottish Intercollegiate Guidelines Network (SIGN), June 2006
Referral Guidelines for suspected cancer
The National Institute for Health and Care Excellence (NICE), June 2005
Scottish referral guidelines for suspected cancer: Quick reference guide
The Scottish Government, March 2009
Guidelines on the diagnosis and management of Barrett's oesophagus
British Society of Gastroenterology, 2013
Minimally invasive oesophagectomy
The National Institute for Health and Care Excellence (NICE), September 2011
Photodynamic therapy for Barrett's oesophagus
The National Institute for Health and Care Excellence (NICE), June 2010
Endoscopic radiofrequency ablation for Barrett's oesophagus
The National Institute for Health and Clinical Excellence (NICE), May 2010
Ablative therapies for Barrett's oesophagus
The National Institute for Health and Care Excellence (NICE), August 2010
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia
The National Institute for Health and Care Excellence (NICE), September 2010
Trastuzumab for treating metastatic gastric cancer
The National Institute for Health and Care Excellence (NICE), November 2010
Palliative photodynamic therapy for advanced oesophageal cancer
The National Institute for Health and Care Excellence (NICE), January 2007
Photodynamic therapy for early oesophageal cancer
The National Institute for Health and Care Excellence (NICE), December 2006
National Oesophago Gastric Cancer Audit
NHS Information Centre
Annual Report 2010, 2012 and 2013
Oesophageal cancer:ESMO clinical practice guidelines for diagnosis, treatment and follow up. Stahl M, Mariette C, Haustermans K and others. Annals of Oncology. 2013. 24 (supplement 6) vi51-vi56.
Recent developments in esophageal adenocarcinoma. Lagergren J and Lagergren P. CA Cancer Journal for Clinicians. 2013. 62: 232-248
Preoperative radiotherapy for esophageal carcinoma. Cochrane Review. Arnott SJ, Duncan W, Gignoux M and others. In: The Cochrane Library, Issue 4, 2005. Art. No.: CD001799. DOI: 10.1002/14651858.CD001799.pub2.
Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Review. Vogt K, Fenlon D, Rhodes S, Malthaner R. In: The Cochrane Library, Issue 3, 2006. CD001556. DOI: 10.1002/14651858.CD001556.pub2.
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Gobs V, Burmeister B, Smithers BM and others. Lancet Oncology, (2007), 8, 226-34.
Oesophageal cancer. Lagergren J and Lagergren P. British Medical Journal, 2010, Vol. 341. Clinical Review. DOI: 10.1136/bmj.c6280
Treatment for Barrett's oesophagus (Review). Rees JRE, Lao-Sirieix P, Wong A and Fitzgerald RC. In The Cochrane Library, Issue 7, 2011. Art No: CD004060. DOI: 10.1002/14651858.CD004060.pub2
Diagnosis and management of Barrett's oesophagus. Janowski J, Barr H, Wang K and Delaney B. BMJ. 2010 vol. 341 p. 597-602
Curative treatment of oesophageal carcinoma:current options and future developments. Wolf MC, Stahl M, Krause B et al. Radiation Oncology. 2011 6 (55)
Multimodality treatment for localized gastro oesophageal cancer. Okines AFC and Cunningham D. Annals of Oncology. 2010. 21 (supplement 7): vii286-vii293.
Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Courrech Staal EFW, Aleman BMP, Boot H et al. British Journal of Surgery. 2010. 97 p. 1482-1496
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma:an updated meta analysis. Sjoquist KM, Burmeister BH, Smithers BM et al. Lancet Oncology. 2011. 12. p. 681-692
Preoperative chemoradiotherapy for esophageal or junctional cancer. van Hagen P, Hulshof MCCM, van Lanschot JJB et al. New England Journal of Medicine. 2012. 366(22). p.2074-2084
Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer. Bystricky B, Okines A and Cunningham D. Drugs. 2011. 71 (5). p. 541-555
Multimodality therapy for adenocarcinoma of the esophagus, gastric cardia and upper gastric third. Reynolds JV, Murphy TJ and Ravi N. Recent Results in Cancer Research. 2010. 182. p. 155-166
Mr William Allum, MBChB, MD, FRCS (Consultant Surgeon)
Dr Tom Crosby, MBBS, MRCP, FRCR (Consultant Clinical Oncologist)
Dee McLean - McDee Art, Medical Illustration
Question about cancer? Contact our information nurse team